Study On The Development Strategy Of Chinese Pre-market Research Industry Chain

At present, the pharmaceutical companies begin their R&D to develop new drugs, which becomes a difficult thing, because the research cost and the closed, independent drug development model can't cater to global trend of synchronizing research. Technology innovation and knowledge innovation are adopted gradually. Basing on the policy target of the industrial structure adjustment and the optimization and upgrading from the fifth plenary session of the seventeenth of central government, and the policy of new medical reforming the Chinese pharmaceutical industry search the R&D activity. Be familiar with the status of pharmaceutical specialization of labor division, and making the industrial development strategy, it should raise the R&D efficiency and effectiveness of domestic pharmaceutical.This paper analyzed development strategy of pre-market research industry chain in detail by the five aspects.At first, the paper discussed research the background and research status. The scholar focus on the develop status and strategy of CRO, but their research can't discuss the pharmaceutical R&D basing on the specialization of labor division.Secondly, the author discussed the developing status of Chinese pre-market research industry. Now Chinese research model of the enterprise arise gradually, but Chinese industry encounter the lower research competence, market not perfect mechanism, and so on. Pharmaceutical service system of pre-market research industry arises along with the changing process of registered review system. It can't match each other between the changing process of pre-market research industry and pharmaceutical technology innovation.Thirdly, the author discussed developing me mechanism of Chinese pre-market research industry. Chinese pharmaceutical industry developing level needed to been improved, and enterprise begin to buy new technology to improve their R&D, which based on the Time Analysis method of pre-market research industry chain. The author found that Chinese R&D activities come from the big enterprise and Chinese R&D activities depend on the lots of resources basing on the Panel Data method. Since the specialization of labor division of Chinese pharmaceutical industry, pre-market research industry chain begins the new developing trend of the mergers, recombining, and differentiations.Fourthly, the author discussed the development strategy of Chinese pharmaceutical pre-market research industry chain. The strategy includes the stakeholders being considered object mainly, governmental strategy of R&D quality safety, and guiding policy of research strategy basing on the specialization of labor division.Finally, the paper draws the conclusion of pre-market research industry developing, and proposes research future outlook.